Shahab Asgharzadeh
Cited by
Cited by
The genetic landscape of high-risk neuroblastoma
TJ Pugh, O Morozova, EF Attiyeh, S Asgharzadeh, JS Wei, D Auclair, ...
Nature genetics 45 (3), 279-284, 2013
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
TF Eleveld, DA Oldridge, V Bernard, J Koster, LC Daage, SJ Diskin, ...
Nature genetics 47 (8), 864-871, 2015
Comparison of RNA-seq and microarray-based models for clinical endpoint prediction
W Zhang, Y Yu, F Hertwig, J Thierry-Mieg, W Zhang, D Thierry-Mieg, ...
Genome biology 16, 1-12, 2015
Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy
KB Challagundla, PM Wise, P Neviani, H Chava, M Murtadha, T Xu, ...
Journal of the National Cancer Institute 107 (7), djv135, 2015
Vα24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages
L Song, S Asgharzadeh, J Salo, K Engell, H Wu, R Sposto, T Ara, ...
The Journal of clinical investigation 119 (6), 1524-1536, 2009
Common variations in BARD1 influence susceptibility to high-risk neuroblastoma
M Capasso, M Devoto, C Hou, S Asgharzadeh, JT Glessner, EF Attiyeh, ...
Nature genetics 41 (6), 718-723, 2009
Chromosome 6p22 locus associated with clinically aggressive neuroblastoma
JM Maris, YP Mosse, JP Bradfield, C Hou, S Monni, RH Scott, ...
New England Journal of Medicine 358 (24), 2585-2593, 2008
Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma
S Asgharzadeh, JA Salo, L Ji, A Oberthuer, M Fischer, F Berthold, ...
Journal of Clinical Oncology 30 (28), 3525, 2012
Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2
LS Metelitsa, HW Wu, H Wang, Y Yang, Z Warsi, S Asgharzadeh, ...
The Journal of experimental medicine 199 (9), 1213-1221, 2004
Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification
S Asgharzadeh, R Pique-Regi, R Sposto, H Wang, Y Yang, H Shimada, ...
Journal of the National Cancer Institute 98 (17), 1193-1203, 2006
NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome
M H÷lzel, S Huang, J Koster, I ěra, A Lakeman, H Caron, W Nijkamp, ...
Cell 142 (2), 218-229, 2010
Revised neuroblastoma risk classification system: a report from the Children's Oncology Group
MS Irwin, A Naranjo, FF Zhang, SL Cohn, WB London, JM Gastier-Foster, ...
Journal of Clinical Oncology 39 (29), 3229, 2021
Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervousá…
SL Gardner, S Asgharzadeh, A Green, B Horn, G McCowage, J Finlay
Pediatric blood & cancer 51 (2), 235-240, 2008
Sparse representation and Bayesian detection of genome copy number alterations from microarray data
R Pique-Regi, J Monso-Varona, A Ortega, RC Seeger, TJ Triche, ...
Bioinformatics 24 (3), 309-318, 2008
Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosedá…
J Fangusaro, J Finlay, R Sposto, L Ji, M Saly, S Zacharoulis, ...
Pediatric blood & cancer 50 (2), 312-318, 2008
Cancer-associated fibroblasts share characteristics and protumorigenic activity with mesenchymal stromal cells
L Borriello, R Nakata, MA Sheard, GE Fernandez, R Sposto, J Malvar, ...
Cancer research 77 (18), 5142-5157, 2017
CASC15-S is a tumor suppressor lncRNA at the 6p22 neuroblastoma susceptibility locus
MR Russell, A Penikis, DA Oldridge, JR Alvarez-Dominguez, L McDaniel, ...
Cancer research 75 (15), 3155-3166, 2015
ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome
S Huang, J Laoukili, MT Epping, J Koster, M H÷lzel, BA Westerman, ...
Cancer cell 15 (4), 328-340, 2009
IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity
D Liu, L Song, J Wei, AN Courtney, X Gao, E Marinova, L Guo, A Heczey, ...
The Journal of clinical investigation 122 (6), 2221-2233, 2012
Prognostic impact of gene expression–based classification for neuroblastoma
A Oberthuer, B Hero, F Berthold, D Juraeva, A Faldum, Y Kahlert, ...
Journal of Clinical Oncology 28 (21), 3506-3515, 2010
The system can't perform the operation now. Try again later.
Articles 1–20